Western Illinois Cancer Treatment Center
Galesburg, Illinois, United States
Cancer treatment center in Galesburg, Illinois
450 Mayo Dr, Galesburg, IL 61401
About Western Illinois Cancer Treatment Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
113
Alliance for Clinical Trials in Oncology
39
SWOG Cancer Research Network
39
ECOG-ACRIN Cancer Research Group
21
NRG Oncology
7
GOG Foundation
6
Gynecologic Oncology Group
5
Wake Forest University Health Sciences
5
Children's Oncology Group
2
ETOP IBCSG Partners Foundation
1
Eastern Cooperative Oncology Group
1
Clinical Trials at Western Illinois Cancer Treatment Center
During the past decade, Western Illinois Cancer Treatment Center conducted 150 clinical trials. In the 10-year time frame, 150 clinical trials started and 85 clinical trials were completed, i.e. on
average, 56.7% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 54 clinical trials were completed. i.e. 120%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
2002-12-01
Completed
171
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
2004-09-01
2013-05-01
Completed
52
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Western Illinois Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 113 trials, followed by "Alliance for Clinical Trials in Oncology" with 39 trials
sponsored, "SWOG Cancer Research Network" with 39 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology"
with 21 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Western Illinois Cancer Treatment Center"
#1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were
collaborators in the rest 33 trials.
Clinical Trials Conditions at Western Illinois Cancer Treatment Center
According to Clinical.Site data, the most researched conditions in "Western Illinois Cancer Treatment Center" are
"Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Western Illinois Cancer Treatment Center" in a lesser frequency.
Clinical Trials Intervention Types at Western Illinois Cancer Treatment Center
Most popular intervention types in "Western Illinois Cancer Treatment Center" are "Drug" (190 trials), "Other" (150 trials), "Biological" (90 trials), "Procedure" (67 trials) and "Radiation" (43 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (43 trials), "Biospecimen Collection" (34 trials) and "Cisplatin" (34 trials). Other intervention names were less common.
Clinical Trials Genders at Western Illinois Cancer Treatment Center
The vast majority of trials in "Western Illinois Cancer Treatment Center" are
199 trials for "All" genders, 37 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Western Illinois Cancer Treatment Center
Currently, there are NaN active trials in "Western Illinois Cancer Treatment Center".
undefined are not yet recruiting,
73 are recruiting,
105 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 42 completed trials in Western Illinois Cancer Treatment Center,
8 suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Western Illinois Cancer Treatment Center, 13 "Phase 1"
clinical trials were conducted, 120 "Phase 2" clinical
trials and 119 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".